Introduction: Thrombocytopenia is commonly observed in pregnant women and can stem from various underlying factors. While it is often benign, in certain cases, it may contribute to negative outcomes for both the mother and fetus.

Objective: To investigate the underlying causes of thrombocytopenia during pregnancy and assess its impact on maternal and fetal health.

Methods: This study included 150 consenting pregnant women beyond 28 weeks of gestation, selected based on their platelet counts. A comprehensive medical history was taken, followed by clinical evaluations and relevant laboratory tests. Maternal and fetal outcomes, along with any treatment-related complications, were documented.

Findings: Thrombocytopenia was identified in 33% of participants. Gestational thrombocytopenia was the most frequently observed type, typically associated with favorable outcomes. However, thrombocytopenia resulting from obstetric conditions such as hypertensive disorders, HELLP syndrome, and certain medical conditions like ITP and viral infections showed a stronger correlation with adverse outcomes.

Conclusion: Although commonly seen in pregnancy, thrombocytopenia should not be overlooked. Proper assessment and close monitoring are essential to initiate early intervention and reduce potential risks for both mother and child.